Discuss current innovations being made in the pharmaceutical sciences with leading experts from BioAgilytix during AAPS PharmSci 360. Our attending team of scientists and executives will be on-hand discuss evolving industry best practices and how BioAgilytix can help support your complex bioanalytical projects with premium science, service, and quality.
You can also pre-register for a time to talk to our scientists one-on-one during the event using the form on this page.
Jim Datin, President and CEO of BioAgilytix, will take part in an executive panel discussion covering the challenges that face the pharmaceutical and biopharmaceutical industries in developing and enhancing intellectual property in the current global registration and outsourcing environment.
Sunday, November 4 | 2:00pm – 4:30pm
*Please note, this is an invitation only event. Participants must have AAPS’ approval to attend. Contact AAPS Director of Corporate Engagement Erik Burns at [email protected] for more information.
Afshin Safavi, Ph.D., Founder and Global Chief Scientific Officer at BioAgilytix and a veteran biochemist, will be presenting and taking part in several panel discussions during AAPS PharmSci 360. His sessions will focus on regulatory challenges impacting the bioanalytical industry, as well as the role of IP in M&A activities for pharma and biopharma.
Monday, November 5 | 8:00am – 10:00am
*Please note, this is an invitation only event. Participants must have AAPS’ approval to attend. Contact AAPS Director of Corporate Engagement Erik Burns at [email protected] for more information.
Wednesday, November 7 | 9:30am – 10:00am
Wednesday, November 7 | 10:30am – 11:00am
Anyone that stops by Booth #721 will have the chance to win a prize to celebrate BioAgilytix’s 10 Year Anniversary. Try your luck and learn more about how BioAgilytix addresses the complexities of large molecule bioanalysis. See you there!
Let us know your availability during AAPS PharmSci 360 and we will schedule a personal session to discuss your specific interests or needs.